ENDRA Life Sciences (NDRA) Change in Inventory (2016 - 2024)
ENDRA Life Sciences' (NDRA) quarterly Change in Inventory came in at -$329476.0 in Q4 2024, down 10154.2% year-over-year from N/an in Q1 2024, and down 138.67% quarter-over-quarter from -$138046.0 in Q2 2024.
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Change in Inventory (2016 - 2024) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Change in Inventory for 9 consecutive years, with -$329476.0 the latest figure, recorded in Q4 2024.
- On a quarterly basis, Change in Inventory fell 10154.2% year-over-year to -$329476.0 in Q4 2024; TTM through Jun 2025 was -$329476.0, a 439.59% decrease from a year earlier, with the FY2024 full-year figure at -$235731.0, down 302.88% from the prior year.
- Change in Inventory was -$329476.0 for Q4 2024 at ENDRA Life Sciences, down from -$138046.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $2.7 million in Q4 2022 and troughed at -$1.7 million in Q2 2022.
- A 5-year average of $133985.4 and a median of $19881.5 in 2020 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 4867.14% in 2020, down 4812400.0% in 2020.
- Over 5 years, Change in Inventory stood at $685944.0 in 2020, then soared by 134.0% to $1.6 million in 2021, then jumped by 68.82% to $2.7 million in 2022, then slumped by 99.88% to $3277.0 in 2023, then tumbled by 10154.2% to -$329476.0 in 2024.
- The last three Change in Inventory figures came in at -$329476.0 (Q4 2024), -$138046.0 (Q2 2024), and $231791.0 (Q1 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 139.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | -3.30 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | -16.70 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | -745,000.00 |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | -164,000.00 |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 1.50 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | 50.70 Mn |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -329,476.00 |
| Jun 30, 2024 | -138,046.00 |
| Mar 31, 2024 | 231,791.00 |
| Dec 31, 2023 | 3,277.00 |
| Jun 30, 2023 | 22,284.00 |
| Mar 31, 2023 | 90,632.00 |
| Dec 31, 2022 | 2.71 Mn |
| Sep 30, 2022 | -259,349.00 |
| Jun 30, 2022 | -1.74 Mn |
| Mar 31, 2022 | 645,680.00 |
| Dec 31, 2021 | 1.61 Mn |
| Sep 30, 2021 | -174,952.00 |
| Jun 30, 2021 | -872,159.00 |
| Mar 31, 2021 | 136,988.00 |
| Dec 31, 2020 | 685,944.00 |
| Sep 30, 2020 | 17,479.00 |
| Jun 30, 2020 | -288,738.00 |
| Mar 31, 2020 | 61,493.00 |
| Dec 31, 2019 | -14,389.00 |
| Sep 30, 2019 | 53,550.00 |